查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1406650

肺監測設備市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品類型、最終用戶、地區和競爭細分

Lung Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年，全球肺部監測設備市場價值為 34.2 億美元，預計到 2028 年，複合CAGR將達到 6.11%。對呼吸系統健康的認知、呼吸系統疾病盛行率的上升以及醫療設備技術的進步。肺部監測設備在呼吸系統疾病的早期檢測、診斷和管理中發揮著至關重要的作用，使其成為現代醫療保健不可或缺的一部分。肺部監測設備包含多種旨在評估和監測肺功能的工具和技術。這些設備對於診斷和治療氣喘、慢性阻塞性肺病 (COPD) 和肺纖維化等呼吸系統疾病至關重要。

有幾個因素正在推動全球肺部監測設備市場的成長。氣喘、慢性阻塞性肺病和肺纖維化等呼吸系統疾病的盛行率正在上升，這主要是由於污染、吸菸和人口老化等因素造成的。這推動了對用於早期診斷和持續管理的肺部監測設備的需求。技術的進步導致了更準確和方便用戶使用的肺部監測設備的開發。無線連接和行動應用程式的整合使患者可以更輕鬆地在家中監測肺部健康狀況。人們對定期肺功能評估重要性的認知不斷提高，鼓勵人們採用肺監測設備作為其日常醫療保健的一部分。全球人口正在老化，老年人更容易患呼吸系統疾病。預計這種人口趨勢將大大增加對肺部監測設備的需求。

主要市場促進因素

市場概況
預測期 2024-2028
2022 年市場規模 34.2億美元
2028 年市場規模 47.8億美元
2023-2028 年CAGR 6.11%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

呼吸系統疾病盛行率上升正在推動全球肺部監測設備市場

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：全球肺監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（肺活量計、脈搏血氧計、二氧化碳描記器、其他）
    • 按最終使用者（醫院和診所、門診護理中心、其他）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖
    • 依產品類型
    • 按最終用戶
    • 按地區

第 5 章：亞太地區肺部監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國肺監測設備
    • 印度肺部監測設備
    • 澳洲肺部監測設備
    • 日本肺部監測設備
    • 韓國肺部監測設備

第 6 章：歐洲肺部監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美肺部監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲肺監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按部署模式
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲肺部監測設備市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非肺部監測設備
    • 沙烏地阿拉伯肺部監測設備
    • 阿拉伯聯合大公國肺部監測設備
    • 埃及肺部監測設備

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品類型發布
  • 併購

第 12 章：全球肺監測設備市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品類型的威脅

第14章：競爭格局

  • 百特國際公司
    • Business Overview
    • Company Snapshot
    • Product Types & Services
    • Current Capacity Analysis
    • Financials (In case of listed)
    • Recent Developments
    • SWOT Analysis
  • 貝克頓迪金森公司
  • ICU 醫療公司
  • 皇家飛利浦公司
  • 馬西莫公司
  • 美敦力公司
  • 日本光電株式會社
  • 瑞思邁公司
  • 泰利福公司。
  • 維亞爾醫療有限公司

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 19509

Global Lung Monitoring Devices Market has valued at USD 3.42 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.11% through 2028. The global lung monitoring devices market has witnessed remarkable growth in recent years, driven by increasing awareness of respiratory health, the rising prevalence of respiratory diseases, and technological advancements in medical devices. Lung monitoring devices play a crucial role in the early detection, diagnosis, and management of respiratory conditions, making them an integral part of modern healthcare. Lung monitoring devices encompass a wide range of tools and technologies designed to assess and monitor lung function. These devices are vital in diagnosing and managing respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, among others.

Several factors are propelling the growth of the global lung monitoring devices market. The prevalence of respiratory diseases such as asthma, COPD, and pulmonary fibrosis is on the rise, primarily due to factors like pollution, smoking, and aging populations. This drives the demand for lung monitoring devices for early diagnosis and continuous management. Advances in technology have led to the development of more accurate and user-friendly lung monitoring devices. The integration of wireless connectivity and mobile apps has made it easier for patients to monitor their lung health at home. Rising awareness about the importance of regular lung function assessment has encouraged individuals to adopt lung monitoring devices as part of their healthcare routine. The global population is aging, and elderly individuals are more susceptible to respiratory disorders. This demographic trend is expected to contribute significantly to the demand for lung monitoring devices.

Key Market Drivers

Market Overview
Forecast Period2024-2028
Market Size 2022USD 3.42 Billion
Market Size 2028USD 4.78 Billion
CAGR 2023-20286.11%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Rising Prevalence of Respiratory Diseases is Driving the Global Lung Monitoring Devices Market

The global lung monitoring devices market has been witnessing impressive growth over the past few years, with the trend expected to continue in the foreseeable future. This growth is driven by various factors, the most prominent of which is the increasing prevalence of respiratory diseases. The global burden of respiratory diseases has been on the rise. According to the World Health Organization (WHO), respiratory diseases accounted for approximately 9% of all global deaths in 2018. This alarming statistic highlights the urgent need for better diagnostic and monitoring tools to manage and mitigate the impact of these diseases. Lung monitoring devices play a crucial role in diagnosing, managing, and monitoring the progression of respiratory conditions, making them indispensable in modern healthcare. The world's population is aging rapidly, and the elderly are more susceptible to respiratory diseases due to weakened immune systems and age-related physiological changes. As the number of elderly individuals continues to grow, so does the demand for lung monitoring devices to manage their respiratory health. This demographic shift is a significant driver of market growth.

Public awareness about the importance of early diagnosis and management of respiratory diseases has grown substantially. Government health initiatives, educational campaigns, and increasing access to healthcare services have contributed to this trend. As a result, more people are seeking medical attention and monitoring their lung health, which further drives the demand for lung monitoring devices. The COVID-19 pandemic served as a stark reminder of the importance of respiratory health. Hospitals and healthcare facilities worldwide experienced an unprecedented demand for respiratory equipment, including ventilators and oxygen monitors. This has led to increased investments in respiratory care infrastructure, including lung monitoring devices, to ensure preparedness for future health crises.

Increasing Healthcare Expenditure is Driving the Global Lung Monitoring Devices Market

One of the primary drivers of the growth in the global lung monitoring devices market is the increasing healthcare expenditure across the globe. Governments and private sectors are investing heavily in healthcare infrastructure, research and development, and innovative medical technologies. The COVID-19 pandemic has further highlighted the importance of robust healthcare systems, leading to a renewed focus on respiratory health and the need for advanced monitoring and diagnostic tools. Many governments have recognized the importance of respiratory health and are taking steps to improve healthcare infrastructure and accessibility. For example, in the United States, the Centers for Medicare & Medicaid Services (CMS) expanded its coverage for remote monitoring devices, including lung monitoring devices, to enhance patient care and reduce healthcare costs. Similar initiatives are being implemented in various other countries, driving the demand for these devices.

Rising Aging Population is Driving the Global Lung Monitoring Devices Market

Aging is an inevitable part of life, and as the global population ages, healthcare systems face a considerable challenge in providing adequate care and support for the elderly. According to the World Health Organization (WHO), the world's population aged 60 years and older is expected to double by 2050, reaching approximately 2 billion people. This demographic shift is attributed to increased life expectancy and declining birth rates in many countries. Aging is often associated with a higher prevalence of chronic diseases, including respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. These conditions require continuous monitoring and management to ensure the well-being of older adults. Lung monitoring devices have emerged as essential tools in this context, helping healthcare providers diagnose and manage respiratory conditions effectively.

As the elderly population grows, so does the prevalence of respiratory diseases. COPD alone affects millions of people worldwide. Lung monitoring devices play a crucial role in diagnosing, managing, and monitoring these conditions, contributing to the market's growth. With a focus on preventive healthcare, many individuals are proactively monitoring their lung health. This trend has driven the demand for portable and home-based lung monitoring devices, such as peak flow meters and pulse oximeters. Governments and healthcare organizations worldwide are allocating more resources to address the healthcare needs of the aging population. This has led to increased investments in medical devices, including lung monitoring devices.

Key Market Challenges

Technological Advancements and Competition

One of the primary challenges facing the lung monitoring devices market is the rapid pace of technological advancements. While these innovations have led to more accurate and efficient devices, they have also intensified competition among manufacturers. Keeping up with the latest technology trends and continually improving devices is essential for staying competitive. Additionally, smaller and newer players entering the market can disrupt established manufacturers, further increasing competition.

Regulatory Compliance

Ensuring regulatory compliance is a significant hurdle in the lung monitoring devices market. Devices used for medical purposes must adhere to stringent regulatory requirements in various countries and regions. Achieving and maintaining regulatory approval is a time-consuming and costly process, which can be particularly challenging for small and medium-sized enterprises (SMEs) looking to enter the market.

High Treatment Costs

The cost of lung monitoring devices can be prohibitive for both healthcare providers and patients. High manufacturing and development costs, coupled with the need for ongoing maintenance and calibration, contribute to the overall expense. Inadequate reimbursement policies in some regions further exacerbate the financial burden on patients, limiting market growth and access to advanced monitoring solutions.

Data Security and Privacy

As lung monitoring devices become more connected and reliant on data transmission, data security and privacy concerns are becoming increasingly prominent. The collection and storage of sensitive patient data require robust security measures to protect against cyberattacks and data breaches. Adhering to stringent data privacy regulations, such as GDPR in Europe, adds another layer of complexity for manufacturers and healthcare providers.

Limited Accessibility in Developing Regions

Access to advanced lung monitoring devices is often limited in developing regions with inadequate healthcare infrastructure. The high costs associated with these devices, along with a lack of trained healthcare professionals to operate them, hinder their widespread adoption in these areas. Bridging this accessibility gap while addressing affordability issues is a significant challenge for market growth.

Integration with Healthcare Systems

The seamless integration of lung monitoring devices with existing healthcare systems and electronic health records (EHRs) is crucial for efficient patient care. However, interoperability issues between devices and EHRs can pose a significant challenge. Establishing standardized communication protocols and ensuring compatibility with various healthcare IT systems is an ongoing challenge for manufacturers.

Patient Education and Awareness

Patients often lack awareness about the benefits of lung monitoring devices and may not fully understand their conditions or the importance of regular monitoring. Healthcare providers must invest in patient education to encourage compliance and proper device usage. Overcoming these educational barriers can be challenging and requires collaborative efforts from healthcare professionals, manufacturers, and advocacy groups.

Key Market Trends

Technological Advancements

Technological advancements have always played a pivotal role in the evolution of healthcare. Among the many fields it has transformed, one that stands out is respiratory health monitoring. The global lung monitoring devices market is experiencing a surge in growth, driven by an array of innovative technologies that are making the diagnosis and management of lung conditions more efficient and precise than ever before.

Advances in sensor technology have led to the development of smart sensors and wearable devices that can continuously monitor lung function. These devices can track parameters like lung capacity, airflow, and oxygen saturation, providing valuable data to patients and healthcare professionals. This real-time monitoring enables early intervention and better disease management. Telemedicine has become a cornerstone of modern healthcare, and it's no different for respiratory health. Lung monitoring devices are now integrated with telemedicine platforms, allowing patients to connect with their healthcare providers remotely. This not only reduces the need for in-person visits but also ensures that patients receive timely care and advice.

Artificial intelligence and machine learning algorithms are being applied to lung monitoring data, enabling more accurate diagnosis and predictive analytics. These technologies can identify patterns and trends that may be missed by human healthcare providers, enhancing the overall quality of care. Lung monitoring devices are becoming smaller, more portable, and user-friendly. This trend allows patients to monitor their lung health conveniently at home, making it easier to track chronic conditions and adjust treatment plans as needed. Seamless integration of lung monitoring devices with Electronic Health Records (EHR) systems streamlines the sharing of patient data between healthcare providers. This leads to better coordination of care and a comprehensive view of a patient's health history.

Segmental Insights

Product Type Insights

Based on the category of Product Type, Spirometers emerged as the dominant player in the global market for Lung Monitoring Devices in 2022. Spirometers are medical devices designed to measure the volume and flow of air inhaled and exhaled by an individual's lungs. They are widely used in various healthcare settings, including hospitals, clinics, and even at home, to assess lung function and diagnose respiratory conditions. Spirometry tests are non-invasive and provide valuable information about lung capacity, airflow, and the presence of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and restrictive lung diseases. Spirometers are renowned for their accuracy in measuring lung function. They provide detailed information about vital parameters such as forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and the FEV1/FVC ratio. These metrics are essential for diagnosing and monitoring respiratory conditions, ensuring accurate treatment plans. Spirometers are versatile devices that can be used across all age groups, from pediatric patients to the elderly. They are also suitable for monitoring a wide range of lung conditions, making them a valuable asset for healthcare providers.

End User Insights

The Hospitals & Clinics segment is projected to experience rapid growth during the forecast period. Hospital pharmacies are increasingly embracing advanced technology and diagnostic devices to enhance patient care. These devices include spirometers, peak flow meters, and pulse oximeters, among others. Spirometers, for instance, are invaluable tools for diagnosing and monitoring respiratory conditions. These devices measure lung function by assessing a patient's ability to inhale and exhale air, helping healthcare professionals make informed decisions about treatment and management. Hospital pharmacies play a crucial role in providing patient-centric care. They serve as intermediaries between healthcare providers and patients, ensuring that prescribed medications and devices are readily available. The close proximity of hospital pharmacies to healthcare facilities makes them an ideal distribution point for lung monitoring devices, as patients can conveniently access them before or after their medical appointments. Furthermore, hospital pharmacists are well-equipped to educate patients on how to use these devices correctly and provide guidance on monitoring their lung health. This patient education and support are essential in improving adherence to treatment plans and ultimately enhancing patient outcomes.

Regional Insights

North America emerged as the dominant player in the global Lung Monitoring Devices market in 2022, holding the largest market share in terms of value. North America's dominance in the global lung monitoring devices market can be attributed to its relentless commitment to technological advancements. The region has been at the forefront of developing cutting-edge respiratory monitoring devices that are both accurate and user-friendly. Innovations such as wearable sensors, mobile apps, and telemedicine solutions have revolutionized the way respiratory conditions are diagnosed and managed. The prevalence of respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea is on the rise worldwide. North America is no exception, with a growing number of individuals suffering from these conditions. The region's aging population, coupled with lifestyle factors such as smoking and pollution, has contributed to the surge in respiratory disorders. As a result, there is an increasing demand for lung monitoring devices in North America to help individuals manage their conditions effectively. North America boasts a robust and well-developed healthcare infrastructure, with access to cutting-edge medical facilities and expertise. This infrastructure allows for widespread adoption of lung monitoring devices across hospitals, clinics, and home healthcare settings. Moreover, the region's healthcare reimbursement systems make it easier for patients to access these devices, further fueling market growth.

Key Market Players

Baxter International Inc.

Becton, Dickinson and Company

ICU Medical Inc.

Koninklijke Philips N.V.

Masimo Corporation

Medtronic plc

Nihon Kohden Corporation

ResMed Inc.

Teleflex Incorporated.

Vyaire Medical, Inc.

Report Scope:

In this report, the Global Lung Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lung Monitoring Devices Market, By Product Type:

  • Spirometers
  • Pulse Oximeters
  • Capnographs
  • Others

Lung Monitoring Devices Market, By End user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Lung Monitoring Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Lung Monitoring Devices Market.

Available Customizations:

  • Global Lung Monitoring Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Lung Monitoring Devices Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product Type (Spirometers, Pulse Oximeters, Capnographs, Others)
    • 4.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 4.2.3. By Region
    • 4.2.4. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Product Type
    • 4.3.2. By End user
    • 4.3.3. By Region

5. Asia Pacific Lung Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type
    • 5.2.2. By End user
    • 5.2.3. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Lung Monitoring Devices Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product Type
        • 5.3.1.2.2. By End user
    • 5.3.2. India Lung Monitoring Devices Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product Type
        • 5.3.2.2.2. By End user
    • 5.3.3. Australia Lung Monitoring Devices Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product Type
        • 5.3.3.2.2. By End user
    • 5.3.4. Japan Lung Monitoring Devices Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product Type
        • 5.3.4.2.2. By End user
    • 5.3.5. South Korea Lung Monitoring Devices Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product Type
        • 5.3.5.2.2. By End user

6. Europe Lung Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End user
    • 6.2.3. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Lung Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End user
    • 6.3.2. Germany Lung Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End user
    • 6.3.3. Spain Lung Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End user
    • 6.3.4. Italy Lung Monitoring Devices Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By End user
    • 6.3.5. United Kingdom Lung Monitoring Devices Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By End user

7. North America Lung Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End user
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Lung Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End user
    • 7.3.2. Mexico Lung Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End user
    • 7.3.3. Canada Lung Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End user

8. South America Lung Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Deployment Mode
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Lung Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End user
    • 8.3.2. Argentina Lung Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End user
    • 8.3.3. Colombia Lung Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End user

9. Middle East and Africa Lung Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End user
    • 9.2.3. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Lung Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End user
    • 9.3.2. Saudi Arabia Lung Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End user
    • 9.3.3. UAE Lung Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End user
    • 9.3.4. Egypt Lung Monitoring Devices Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product Type
        • 9.3.4.2.2. By End user

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Type Launches
  • 11.3. Mergers & Acquisitions

12. Global Lung Monitoring Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product Type

14. Competitive Landscape

  • 14.1. Baxter International Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Product Types & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Becton, Dickinson and Company
  • 14.3. ICU Medical Inc.
  • 14.4. Koninklijke Philips N.V.
  • 14.5. Masimo Corporation
  • 14.6. Medtronic plc
  • 14.7. Nihon Kohden Corporation
  • 14.8. ResMed Inc.
  • 14.9. Teleflex Incorporated.
  • 14.10. Vyaire Medical, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer